Adverse effects in children after unintentional buprenorphine exposure.

Pediatrics

Program in Medical Toxicology, Division of Emergency Medicine, Children's Hospital Boston, Boston, Massachusetts, USA.

Published: October 2006

Buprenorphine in sublingual formulation was recently introduced to the American market for treatment of opioid dependence. We report a series of 5 toddlers with respiratory and mental-status depression after unintentional buprenorphine exposure. Despite buprenorphine's partial agonist activity and ceiling effect on respiratory depression, all children required hospital admission and either opioid-antagonist therapy or mechanical ventilation. Results of routine urine toxicology screening for opioids were negative in all cases. Confirmatory testing was sent for 1 child and returned with a positive result. The increasing use of buprenorphine as a home-based therapy for opioid addiction in the United States raises public health concerns for the pediatric population.

Download full-text PDF

Source
http://dx.doi.org/10.1542/peds.2006-0948DOI Listing

Publication Analysis

Top Keywords

unintentional buprenorphine
8
buprenorphine exposure
8
adverse effects
4
effects children
4
children unintentional
4
buprenorphine
4
exposure buprenorphine
4
buprenorphine sublingual
4
sublingual formulation
4
formulation introduced
4

Similar Publications

Article Synopsis
  • This study reviewed opioid exposures in young children, specifically looking at data from America's Poison Centers® between 2016 and 2023, to assess the impact of fentanyl and medications for opioid use disorder.
  • Out of 34,632 reports, most exposures (96.7%) were unintentional, with a median age of exposure being 2 years. While overall reported exposures decreased by 57.5%, there was a concerning 300% increase in deaths and major effects.
  • The study emphasizes the importance of improving poisoning prevention strategies, as medications like buprenorphine and methadone showed a significant association with severe effects, alongside rising cases of fentanyl and heroin exposure.
View Article and Find Full Text PDF

Patient and navigator experiences with the opioid use disorder treatment system in Philadelphia, PA.

J Subst Use Addict Treat

December 2024

Department of Family and Community Medicine, Thomas Jefferson University, 1015 Walnut Street, Philadelphia, PA 19107, USA. Electronic address:

Background: In 2022, 1413 people in Philadelphia died of an unintentional drug overdose. Addressing the complex challenges within the opioid use disorder (OUD) treatment system requires a comprehensive grasp of multiple system-level siloes from the perspective of patients who are accessing services and certified recovery specialists. Identifying facilitators and barriers to treatment entry and retention are critical.

View Article and Find Full Text PDF
Article Synopsis
  • A 14-year-old patient with severe opioid and stimulant use disorders was hospitalized for a fentanyl overdose and started on buprenorphine.
  • After struggling with adherence, they were switched to long-acting injectable buprenorphine and began receiving behavioral treatment with contingency management for better support.
  • Over 19 months, the patient showed improved engagement and maintained abstinence, highlighting the potential benefits of LAIB and the need for more research on community-based treatments for adolescents with opioid use disorder.
View Article and Find Full Text PDF

Early Surgical Excision of Necrotic Tissue Following Unintentional Dermal Injection of Extended-Release Buprenorphine.

J Addict Med

October 2024

From the Department of General Internal Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA (CT, VL, JM, JT, JB); and Grayken Center for Addiction, Boston Medical Center, Boston, MA, Boston, MA (JT).

Introduction: Extended-release subcutaneous buprenorphine is an increasingly common treatment for opioid use disorder. Serious adverse events are rare and may be poorly understood. This report describes an early surgical intervention to address tissue necrosis resulting from misplaced subcutaneous buprenorphine injection.

View Article and Find Full Text PDF

Pediatric population represents the most vulnerable and at risk for unintentional poisoning, with children younger than 6 years old accounting for nearly half of poison exposures. Poisoning is a time-dependent emergency. The need to reach a scientific agreement on diagnostic protocol and treatment seems to be crucial to reduce morbidity and mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!